“We are leveraging our cutting-edge science to develop lifesaving and life altering therapies for patients with rare immunological diseases.”
Søren Tulstrup, President and CEO
May 23, 2022
May 13, 2022
Events & Webcasts
Annual General Meeting 2022
William Blair’s Biotech Focus Conference 2022
Half year 2022 report
Introduction to Hansa
Søren Tulstrup, President & CEO
From our headquarters in Lund, Sweden, we reach around the world. Our dedicated team includes experienced and courageous specialists driven by our purpose to develop lifesaving and life altering therapies for patients living with rare immunological diseases.
Since our founding in 2007, we have worked in cross functional and agile teams. We are gender-balanced, representing a vast number of nationalities and see diversity as an enabler for reaching our corporate objectives. The recruitment of highly motivated, experienced and talented team players supports our development towards a fully integrated global biopharmaceutical company.
In 2020 and 2021, Hansa Biopharma AB was certified as A Great Place to Work company by the independent institute Great Place to Work® , a global authority on workplace culture, employee experience and leadership behaviour. We are immensely proud.